BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Allergan Inc. (AGN) Seeks Sale of Obesity Biz by First Quarter


1/8/2013 8:23:21 AM

Allergan Inc. (AGN), the maker of the Botox wrinkle treatment, has attracted interest for its weight- loss unit and wants to sell the business by the end of the first quarter, Chief Executive Officer David Pyott said. Allergan said in October it would consider a sale of the obesity business, including the Lap-Band device, as revenue declined and concerns rose about the weight-loss procedure. “There’s a lot of interest, some strategic companies, but especially in terms of numbers, private equity players,” Pyott said yesterday in an interview at the annual health-care conference sponsored by JPMorgan Chase & Co. (JPM) in San Francisco. “Sometime in the first quarter this will come to pass.” Allergan in November said it would buy a unit of SkinMedica Inc. for $350 million to expand its skin-care business. Botox, with about $1.6 billion in 2011 sales, is the Irvine, California-based company’s best seller. Revenue for the obesity intervention unit will be about $160 million in 2012, the company said in a statement in October. Sales declined from $203.1 million last year and a peak of $296 million in 2008, the company reported.

Read at BusinessWeek


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->